S-EPMC9944522 - The CRAFITY score can identify patients with hepatocellular carcinoma showing poor response to treatment with atezolizumab and bevacizumab - OmicsDI

Unknown

Dataset Information

The CRAFITY score can identify patients with hepatocellular carcinoma showing poor response to treatment with atezolizumab and bevacizumab

ABSTRACT:

SUBMITTER: Lieb S

PROVIDER: S-EPMC9944522 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature